![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
-1 Receptors (
1 Binding Sites) in NG108-15 Cells
Cellular Pathobiology Unit, Cellular Neurobiology Research Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, Baltimore, Maryland
The
-1 receptors bind diverse kinds of psychoactive compounds,
including cocaine, and translocate upon stimulation by these compounds.
However, the exact intracellular localization and dynamics of
-1
receptors have been unclear. We recently found that
-1 receptors
specifically localize on cholesterol-enriched loci on the endoplasmic
reticulum (ER) membrane that function as neutral lipid storage sites (i.e., ER
lipid droplets or ER-LDs) from which neutral lipids bud out to form cytosolic
lipid droplets. By combining immunocytochemistry and real-time monitoring of
enhanced yellow fluorescent protein (EYFP)-tagged
-1 receptors
(Sig-1R-EYFP) in living cells, we characterized the
-1 receptor
translocation in this study. (+)-Pentazocine, a selective
-1 receptor
agonist, causes a significant decrease of
-1 receptors in ER-LDs and a
diffused distribution of
-1 receptors over the entire endoplasmic
reticulum reticular network in NG108-15 cells. In the presence of
-1
receptor agonists, Sig-1R-EYFP move out from ER-LDs and slide along the
endoplasmic reticulum network toward nuclear envelope and the tip of neurites.
Fluorescence recovery after photobleaching analysis demonstrates that
Sig-1R-EYFP on endoplasmic reticulum reticular network are highly mobile
compared with those in ER-LDs. A sucrose gradient fractionation study shows
that (+)-pentazocine shifts
-1 receptors from ER-LD membranes to higher
density membranes. These results indicate that
-1 receptors localize on
ER-LDs and upon stimulation translocate on continuous endoplasmic reticulum
reticular network toward peripheries of cells. Because
-1 receptors
specifically target ER lipid storage sites and compartmentalize neutral lipids
therein, these results suggest that
-1 receptors' dynamic translocation
might affect lipid transport and distribution in neuronal cells.
Address correspondence to: Dr. Tsung-Ping Su, Cellular Pathobiology Unit, Cellular Neurobiology Research Branch, TRIAD Bldg., Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Department of Health and Human Services, 5500 Nathan Shock Dr., Baltimore, MD 21224. E-mail: tsu{at}intra.nida.nih.gov
This article has been cited by other articles:
![]() |
Y. Dun, M. Thangaraju, P. Prasad, V. Ganapathy, and S. B. Smith Prevention of Excitotoxicity in Primary Retinal Ganglion Cells by (+)-Pentazocine, a Sigma Receptor-1 Specific Ligand Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4785 - 4794. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cormaci, T. Mori, T. Hayashi, and T.-P. Su Protein Kinase A Activation Down-Regulates, Whereas Extracellular Signal-Regulated Kinase Activation Up-Regulates {sigma}-1 Receptors in B-104 Cells: Implication for Neuroplasticity J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 202 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yagasaki, T. Numakawa, E. Kumamaru, T. Hayashi, T.-P. Su, and H. Kunugi Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release J. Biol. Chem., May 5, 2006; 281(18): 12941 - 12949. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hayashi and T.-P. Su Sigma-1 receptors at galactosylceramide-enriched lipid microdomains regulate oligodendrocyte differentiation PNAS, October 12, 2004; 101(41): 14949 - 14954. [Abstract] [Full Text] [PDF] |
||||